Skip to main content
SpringerLink
Log in

Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer

  • Correspondence
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stuebs F, Heidemann S, Caliebe A, Mundhenke C, Arnold N (2017) CDH1 mutation screen in a BRCA1/2-negative familial breast-/ovarian cancer cohort. Arch Gynecol Obstet (in press)

  2. van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O’Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 52(6):361–374

    Article  PubMed  PubMed Central  Google Scholar 

  3. Risinger JI, Berchuck A, Kohler MF, Boyd J (1994) Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7(1):98–102

    Article  CAS  PubMed  Google Scholar 

  4. Figueiredo J, Söderberg O, Simões-Correia J, Grannas K, Suriano G, Seruca R (2013) The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur J Hum Genet 21(3):301–309

    Article  CAS  PubMed  Google Scholar 

  5. Benusiglio PR, Malka D, Rouleau E, De Pauw A, Buecher B, Nogues C, Fourme E, Colas C, Coulet F, Warcoin M, Grandjouan S, Sezeur A, Laurent-Puig P, Moliere D, Tlemsani C, Di Maria M, Byrde V, Delaloge S, Blayau M, Caron O (2013) CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 50(7):486–489

    Article  CAS  PubMed  Google Scholar 

  6. Petridis C, Shinomiya I, Kohut K, Gorman P, Caneppele M, Shah V, Troy M, Pinder SE, Hanby A, Tomlinson I, Trembath RC, Roylance R, Simpson MA, Sawyer EJ (2014) Germline CDH1 mutations in bilateral lobular carcinoma in situ. Br J Cancer 18 110(4):1053–1057

    Article  CAS  Google Scholar 

  7. Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE, Huntsman D (2007) Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 44(11):726–731

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Xie ZM, Li LS, Laquet C, Penault-Llorca F, Uhrhammer N, Xie XM, Bignon YJ (2011) Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer. Cancer 117(14):3112–3117

    Article  CAS  PubMed  Google Scholar 

  9. Corso G, Figueiredo J, Biffi R, Trentin C, Bonanni B, Feroce I, Serrano D, Cassano E, Annibale B, Melo S, Seruca R, De Lorenzi F, Ferrara F, Piagnerelli R, Roviello F, Galimberti V (2014) E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev 33(4):1081–1094

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This manuscript was supported by the project “Understanding how CDH1 germline mutations affect hereditary lobular breast cancer”, Italian Ministry of Health, grant number GR-2016-02361655.

Author information

Authors and Affiliations

  1. Division of Breast Cancer Surgery, European Institute of Oncology, Via G. Ripamonti 435, 20141, Milan, Italy

    G. Corso, P. Veronesi & V. Galimberti

  2. Division of Cancer Prevention and Genetics, European Institute of Oncology, Via G. Ripamonti 435, 20141, Milan, Italy

    B. Bonanni

  3. Faculty of Medicine, University of Milan, Milan, Italy

    P. Veronesi

Authors
  1. G. Corso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Bonanni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Veronesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. Galimberti
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

GC: Study concept and manuscript writing. BB: Manuscript revision. VG: Manuscript approval.

Corresponding author

Correspondence to G. Corso.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Corso, G., Bonanni, B., Veronesi, P. et al. Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer. Arch Gynecol Obstet 297, 1067–1068 (2018). https://doi.org/10.1007/s00404-018-4705-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-018-4705-9

Search

Navigation